Kennedy Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-81,196	Closed	-$623K	–	670
2020 Q1	$623K	Buy	81,196 +11,457	+16%	+$87.9K	0.02%	600
2019 Q4	$580K	Sell	69,739 -670	-1%	-$5.57K	0.01%	649
2019 Q3	$520K	Sell	70,409 -5,098	-7%	-$37.7K	0.01%	635
2019 Q2	$847K	Buy	+75,507	New	+$847K	0.02%	620